38 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33553989 | Genomic Mechanisms Governing Mineral Homeostasis and the Regulation and Maintenance of Vitamin D Metabolism. | 2021 Jan | 1 |
2 | 32165494 | The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity. | 2020 May 1 | 1 |
3 | 32319119 | Noteworthy idiosyncrasies of 1α,25-dihydroxyvitamin D3 kinetics for extrapolation from mouse to man: Commentary. | 2020 Mar | 1 |
4 | 32850381 | Knockdown of CYP24A1 Aggravates 1α,25(OH)2D3-Inhibited Migration and Invasion of Mouse Ovarian Epithelial Cells by Suppressing EMT. | 2020 | 2 |
5 | 33249854 | A Naringin- and Icariin-Contained Herbal Formula, Gushukang, Ameliorated Aged Osteoporosis of Aged Mice with High Calcium Intake. | 2020 | 1 |
6 | 30553931 | Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D3 and related intermediates in serum of mice treated with 24,25-dihydroxyvitamin D3. | 2019 Apr | 4 |
7 | 30875566 | Preclinical Prevention Trial of Calcitriol: Impact of Stage of Intervention and Duration of Treatment on Oral Carcinogenesis. | 2019 Apr | 1 |
8 | 31439663 | A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues. | 2019 Sep 27 | 2 |
9 | 31698751 | Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts. | 2019 Nov 6 | 1 |
10 | 29771914 | Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3. | 2018 | 1 |
11 | 29986424 | Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum. | 2018 Jul 6 | 1 |
12 | 28492801 | Orthotopic tumorgrafts in nude mice as a model to evaluate calcitriol effects in breast cancer. | 2017 Nov | 1 |
13 | 26586377 | Physiologically-Based Pharmacokinetic-Pharmacodynamic Modeling of 1α,25-Dihydroxyvitamin D3 in Mice. | 2016 Feb | 2 |
14 | 27106018 | Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention. | 2016 Oct | 3 |
15 | 25829051 | PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation. | 2015 Jul | 3 |
16 | 26148725 | FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes. | 2015 Sep | 1 |
17 | 26441239 | A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice. | 2015 Dec | 1 |
18 | 24365583 | Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol. | 2014 Apr | 2 |
19 | 23505097 | Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. | 2013 Sep | 1 |
20 | 23897575 | Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice. | 2013 Oct | 1 |
21 | 22179019 | Regulation of mouse Cyp24a1 expression via promoter-proximal and downstream-distal enhancers highlights new concepts of 1,25-dihydroxyvitamin D(3) action. | 2012 Jul 1 | 1 |
22 | 20591973 | CYP24A1 inhibition enhances the antitumor activity of calcitriol. | 2010 Sep | 5 |
23 | 17244627 | Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol. | 2007 Mar 23 | 6 |
24 | 17280828 | Characterization of Vitamin D insensitive prostate cancer cells. | 2007 Mar | 1 |
25 | 17556365 | Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo. | 2007 Aug 3 | 1 |
26 | 16691293 | Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. | 2006 Jun | 1 |
27 | 17237620 | Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. | 2006 | 1 |
28 | 15647825 | 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. | 2005 Feb | 3 |
29 | 16148162 | Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. | 2005 Sep 15 | 1 |
30 | 12674324 | Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. | 2003 Apr | 2 |
31 | 11437358 | Modulation by cAMP of 1alpha,25-dihydroxyvitamin D3 sensitivity of murine erythroleukemia cells. | 2001 Jul 15 | 6 |
32 | 10198318 | Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH. | 1999 Apr | 1 |
33 | 9792969 | Effect of 26,26,26,27,27,27-Hexafluoro-1,25-dihydroxyvitamin D3 on the expression of vitamin-D-responsive genes in vitamin-D-deficient mice. | 1998 Dec | 2 |
34 | 9165006 | Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1alpha,25-dihydroxyvitamin D3. | 1997 Jun | 6 |
35 | 7592579 | Retinoid X receptor acts as a hormone receptor in vivo to induce a key metabolic enzyme for 1,25-dihydroxyvitamin D3. | 1995 Oct 13 | 2 |
36 | 7802698 | Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum. Possible role in decrease of plasma 1 alpha,25-dihydroxyvitamin D3. | 1994 Nov 29 | 3 |
37 | 2162697 | Cultured osteoblasts from normal and hypophosphatemic mice: calcitriol receptors and biological response to the hormone. | 1990 | 1 |
38 | 3682815 | Regulation of 24-hydroxylase activity in mouse skin fibroblast by cholecalciferol derivatives, triamcinolone acetonide and a calcium modulating agent, nicardipine. | 1987 Nov | 2 |